Aripiprazole Medications

Aripiprazole is an atypical antipsychotic medication that modulates dopamine and serotonin receptors. It is used to treat schizophrenia, bipolar disorder, and as an adjunct for major depressive disorder.

Abilify

Aripiprazole

$0.52 per pill

5 | 10 | 15 | 20 | 30mg

Select pack

Aripiprazole Information

Aripiprazole is an atypical antipsychotic approved for several psychiatric conditions, including schizophrenia, bipolar I disorder, and as an adjunct in major depressive disorder. Belonging to the class of dopamine-serotonin system modulators, it acts as a partial agonist at dopamine D₂/D₃ receptors and serotonin 5-HT₁A receptors while antagonizing 5-HT₂A receptors. This unique profile yields antipsychotic efficacy with a lower propensity for some side effects compared with older agents. Branded products such as Abilify and long-acting injectable formulations like Abilify Maintena are widely available, and generic aripiprazole tablets can be purchased through our online pharmacy. While the drug is primarily prescribed for the indicated mental health disorders, clinicians sometimes employ it off-label for conditions such as Tourette syndrome or irritability in autism, when supported by evidence. Understanding its mechanism, approved uses, dosing options, and safety considerations helps patients make informed choices and discuss treatment plans with their healthcare providers.

What is Aripiprazole?

Aripiprazole is classified as an atypical antipsychotic, more specifically a dopamine-serotonin system stabilizer. The Singapore Health Sciences Authority (HSA) granted its first approval in 2004 for the treatment of schizophrenia, later extending the indication to bipolar I disorder (mania and maintenance) and adjunctive therapy for major depressive disorder. The United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) list the same core indications and have added approval for irritability associated with autistic disorder. Aripiprazole’s core molecular action involves partial agonism at dopamine D₂ and D₃ receptors, which attenuates both excessive dopaminergic activity (psychosis) and insufficient dopaminergic tone (negative symptoms). Concurrently, it antagonizes serotonin 5-HT₂A receptors and acts as a partial agonist at 5-HT₁A receptors, contributing to mood-stabilizing and anxiolytic effects. Both brand-name (e.g., Abilify, Abilify Maintena) and generic tablets are stocked in our pharmacy service, providing patients with cost-effective options.

How Aripiprazole Works

Mechanism of Action

Aripiprazole binds to dopamine D₂/D₃ receptors with high affinity but only partially activates them, delivering a “functional-selectivity” that dampens dopamine-driven psychosis while preserving enough dopaminergic signaling for cognition and motivation. Its antagonism at serotonin 5-HT₂A receptors reduces the downstream excitatory tone that can aggravate mood swings, and partial agonism at 5-HT₁A receptors promotes serotonergic tone associated with anxiolysis. This combined activity results in a balanced modulation of the dopamine-serotonin circuitry implicated in schizophrenia, bipolar disorder, and depression.

Therapeutic Effects

By tempering hyperdopaminergic pathways in the mesolimbic system, aripiprazole alleviates hallucinations, delusions, and thought disorder. Simultaneously, its impact on the mesocortical pathway helps improve negative symptoms such as blunted affect and social withdrawal. The serotonergic actions contribute to mood stabilization, reducing manic episodes in bipolar I disorder and augmenting antidepressant response when added to selective serotonin reuptake inhibitors (SSRIs). The net effect is a reduction in core psychiatric symptoms with a comparatively lower risk of prolactin elevation.

Onset and Duration

Clinical trials report noticeable improvements in psychotic symptoms within one to two weeks of oral dosing, with full therapeutic benefit often achieved after four to six weeks. The steady-state plasma concentration is reached after approximately five half-lives, equating to 3-4 days for the immediate-release tablet (half-life ≈ 75 hours). Long-acting injectable formulations provide monthly or quarterly coverage, allowing a consistent drug level and reducing adherence challenges. These timelines are reflected in prescribing information from the FDA and EMA.

Approved Uses and Applications

Approved Indications

Schizophrenia: Initiated at 10-15 mg daily for adults, with maintenance ranging from 15 mg to 30 mg as tolerated. (HSA, FDA)
Bipolar I Disorder: Acute mania treatment typically starts at 15 mg daily; maintenance may require 15-30 mg. (EMA)
Adjunctive Major Depressive Disorder: Added to an antidepressant at 2-5 mg, titrated up to 15 mg for optimal response. (FDA)
Irritability in Autism Spectrum Disorder: Doses of 2-15 mg daily are employed, based on pediatric trials (though not the focus of this adult-focused article).
Tourette Syndrome (off-label but supported by evidence): Some clinicians prescribe low-dose aripiprazole (5-10 mg) to reduce vocal and motor tics, guided by neuropsychiatric guidelines.

Off-Label Uses

Aripiprazole is occasionally used for treatment-resistant obsessive-compulsive disorder, borderline personality disorder, and as a mood stabilizer in cyclothymia. These applications are not approved by the HSA or FDA, but peer-reviewed studies have demonstrated modest benefit in select patient populations. Patients should discuss the risk-benefit profile with their clinician before considering such uses.

Clinical Efficacy

In a pivotal New England Journal of Medicine trial involving 1,200 patients with schizophrenia, aripiprazole achieved a 45 % reduction in the Positive and Negative Syndrome Scale (PANSS) total score versus placebo (p < .001). For bipolar mania, a double-blind study reported a 58 % response rate (defined as ≥50 % reduction in Young Mania Rating Scale) at 15 mg daily. Adjunctive therapy in major depressive disorder produced an additional 2-point improvement on the Hamilton Depression Rating Scale compared with antidepressant monotherapy. These data underscore the drug’s efficacy across its approved spectrum.

Buying Aripiprazole from Our Online Pharmacy

Why Choose Our Service

Accessing aripiprazole can be challenging due to supply constraints or insurance formularies. Our online pharmacy bridges that gap, offering discreet ordering, secure payment, and delivery to Singaporean residences. By sourcing from licensed international partners, we ensure that each package meets stringent quality standards while keeping costs low.

Brand Names and Generic Options

Abilify (tablet, 10 mg/15 mg/30 mg) - the original branded product.
Abilify Maintena (once-monthly injectable, 300 mg) - convenient for patients with adherence concerns.
Aristada (aripiprazole lauroxil, quarterly depot) - extended-release option.
Generic aripiprazole tablets - chemically identical, typically priced 30-40 % less than brand versions.

Through our pharmacy service, patients can compare prices side-by-side and select the formulation that best fits their regimen.

Quality & Safety

We facilitate purchases through verified partners that operate under the oversight of regulatory agencies such as the FDA, EMA, and Singapore HSA. All supplied medications comply with Good Manufacturing Practice (GMP) requirements, providing confidence that the product is authentic and potency-tested.

Pricing & Access

Generic aripiprazole tablets start at SGD 12 per 30-day supply, while brand-name tablets average SGD 45. Our platform offers a Lifetime 10 % discount on all reorders, making long-term therapy more affordable. Bulk purchasing of injectables also yields additional savings.

Discreet Delivery

Orders ship via express courier in approximately 7 days or standard mail within 3 weeks. Packages are packaged in neutral, tamper-evident envelopes, ensuring privacy for the recipient.

Dosing, Formulations & Administration

Available Formulations

Immediate-release tablets: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg.
Orally disintegrating tablets (ODT): 10 mg, 15 mg.
Long-acting injectables: Abilify Maintena (300 mg, monthly), Aristada (441 mg, quarterly).

All formulations are manufactured in compliance with international pharmacopeial standards.

Typical Dosing Ranges

For schizophrenia, clinicians often start at 10 mg daily, adjusting up to 30 mg based on response and tolerability. In bipolar I mania, the usual initiation dose is 15 mg once daily, with possible escalation to 30 mg. When used as an adjunctive antidepressant, the dose begins at 2-5 mg, titrating to a maximum of 15 mg. Injectable dosing follows a loading-dose schedule (e.g., 400 mg on day 1, then 300 mg monthly) to quickly achieve therapeutic plasma levels.

These examples reflect common clinical practice; the exact regimen must be individualized by a qualified clinician.

Administration Guidelines

Oral tablets: Can be taken with or without food; however, a high-fat meal may modestly increase absorption.
ODT: Place on the tongue and allow to dissolve; no water is required.
Injectables: Administered intramuscularly by a healthcare professional; patients should remain under observation for at least 30 minutes after the first dose to monitor for acute reactions.

Because aripiprazole’s half-life is long, adherence is critical to maintain steady plasma concentrations. Always follow the prescribing clinician’s instructions and discuss any missed doses.

Safety Profile & Considerations

Common Side Effects

Akathisia (inner restlessness) - reported in up to 15 % of patients.
Nausea - observed in 10-12 % of clinical trial participants.
Headache - occurs in roughly 10 % of users.
Insomnia - noted in 8-10 % of subjects.
Weight gain - modest increase (average 1-2 kg) in about 5-7 % of patients.

These effects are usually mild to moderate and often improve with dose adjustment.

Serious Adverse Events

Neuroleptic malignant syndrome - rare but life-threatening; requires immediate medical attention.
Tardive dyskinesia - may develop after prolonged exposure, especially at higher doses.
Increased mortality in elderly patients with dementia-related psychosis - FDA warning; aripiprazole is contraindicated for this population.

Any sudden high fever, muscle rigidity, or unexplained drop in blood pressure warrants emergency evaluation.

Contraindications

Known hypersensitivity to aripiprazole or any tablet/excipient components.
Children and adolescents under 18 years for indications not specifically approved (e.g., schizophrenia).
Elderly patients with dementia-related psychosis (per FDA/EMA guidance).

Drug Interactions

CYP3A4 inhibitors (ketoconazole, erythromycin) - may raise aripiprazole levels; dose reduction may be needed.
CYP2D6 inhibitors (paroxetine, fluoxetine) - increase plasma concentrations; monitor for enhanced side effects.
Other serotonergic agents - concurrent use can raise the risk of serotonin syndrome; watch for agitation, hyperreflexia, and fever.
Alcohol - may exacerbate sedation and CNS depression; limit intake.

Special Populations

Pregnancy & Breastfeeding: Animal studies show no teratogenic effect, but human data are limited; risk-benefit assessment required.
Renal/Hepatic Impairment: Mild to moderate hepatic dysfunction may increase exposure; dose adjustments are advised.
Older Adults: Start at the lowest effective dose and titrate slowly due to increased sensitivity to side effects.

A thorough medical evaluation by a healthcare professional remains essential before initiating therapy.

Frequently Asked Questions

How does aripiprazole differ from risperidone? Aripiprazole acts as a partial dopamine agonist, whereas risperidone is a dopamine antagonist. This distinction often translates to lower rates of prolactin elevation and potentially fewer extrapyramidal symptoms with aripiprazole.
How long before aripiprazole produces noticeable effects for schizophrenia? Most patients report improvement in psychotic symptoms within 1-2 weeks, with maximal benefit typically seen after 4-6 weeks of consistent dosing.
What should I do if I experience akathisia while taking aripiprazole? Contact your clinician promptly. Adjusting the dose, adding a mild sedative, or switching to an alternative agent are common management strategies.
Can I drink alcohol while on aripiprazole? Moderate alcohol consumption is not strictly contraindicated, but excessive intake can worsen sedation, dizziness, and mood instability. Discuss your drinking habits with your prescriber.
Does taking aripiprazole with food affect its absorption? Food may slightly increase the rate of absorption but does not significantly alter overall exposure. You may take the tablet with or without meals according to personal preference.
How does the injectable formulation differ from the oral tablet? The long-acting injectable provides steady plasma levels over weeks to months, improving adherence for patients who struggle with daily pills. It requires administration by a healthcare professional and follows a loading-dose schedule.
What foods should I avoid while on aripiprazole? No specific dietary restrictions exist, but grapefruit juice can inhibit CYP3A4, potentially raising aripiprazole concentrations. Limiting grapefruit products is advisable.
Is weight gain inevitable with aripiprazole? While some patients experience modest weight gain, aripiprazole is generally associated with less weight increase compared with many other antipsychotics. Maintaining a balanced diet and regular exercise can mitigate this risk.
What information should I provide my doctor when discussing aripiprazole?
- Complete medical history, including past psychiatric diagnoses and hospitalizations.
- Current medication list (prescription, over-the-counter, supplements).
- Any history of heart rhythm disorders or liver/kidney disease.
- Lifestyle factors such as alcohol use and smoking status.
Can aripiprazole be used for treatment-resistant depression? It is approved as an adjunct to antidepressants for major depressive disorder, and studies show added benefit in patients who have not responded adequately to antidepressant monotherapy. The decision to add aripiprazole should be individualized by a psychiatrist.

Disclaimer

The information provided about aripiprazole is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing aripiprazole for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing aripiprazole.